BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9721709)

  • 21. Effect of Tumor Size and Minimal Extrathyroidal Extension in Patients with Differentiated Thyroid Cancer.
    Tam S; Amit M; Boonsripitayanon M; Busaidy NL; Cabanillas ME; Waguespack SG; Gross ND; Grubbs EG; Williams MD; Lai SY; Sturgis EM; Zafereo ME
    Thyroid; 2018 Aug; 28(8):982-990. PubMed ID: 29936892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
    Shaha AR
    Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Surgical treatment of differentiated thyroid carcinoma and analysis of recurrence-related factors].
    Chen FJ; Li QL; Zeng ZY; Song M; Yang AK; Zhang Q
    Ai Zheng; 2004 Nov; 23(11):1311-6. PubMed ID: 15522180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors in patients with differentiated thyroid carcinoma.
    Steinmüller T; Klupp J; Rayes N; Ulrich F; Jonas S; Gräf KJ; Neuhaus P
    Eur J Surg; 2000 Jan; 166(1):29-33. PubMed ID: 10688213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical treatment of papillary and follicular thyroid carcinoma.
    Lin JD; Jeng LB; Chao TC; Weng HF; Huang HS
    Int Surg; 1996; 81(1):61-6. PubMed ID: 8803709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
    Haq M; Harmer C
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognostic factors of papillary carcinomas of the thyroid gland--retrospective multivariate analysis of 227 patients with median follow-up 130 months].
    Kure Y
    Nihon Geka Gakkai Zasshi; 1992 Nov; 93(11):1420-6. PubMed ID: 1448049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiated Thyroid Cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy.
    Piccardo A; Puntoni M; Bottoni G; Treglia G; Foppiani L; Bertoli M; Catrambone U; Arlandini A; Dib B; Altrinetti V; Massollo M; Bossert I; Cabria M; Bertagna F; Giovanella L
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):926-934. PubMed ID: 27966046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of lymph node yield and lymph node ratio in well-differentiated thyroid carcinoma.
    Beal SH; Chen SL; Schneider PD; Martinez SR
    Am Surg; 2010 Jan; 76(1):28-32. PubMed ID: 20135936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancer.
    Sabet A; Binse I; Grafe H; Ezziddin S; Görges R; Poeppel TD; Bockisch A; Rosenbaum-Krumme SJ
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1988-94. PubMed ID: 27118127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.
    Asari R; Koperek O; Scheuba C; Riss P; Kaserer K; Hoffmann M; Niederle B
    Ann Surg; 2009 Jun; 249(6):1023-31. PubMed ID: 19474675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioactive iodine (RAI) therapy for distantly metastatic differentiated thyroid cancer (DTC) in juvenile versus adult patients.
    Kammori M; Fukumori T; Sugishita Y; Hoshi M; Shimizu K; Yamada T
    Endocr J; 2015; 62(12):1067-75. PubMed ID: 26424174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of neck dissection on survival in well-differentiated thyroid cancer: a multivariate analysis of 218 cases.
    Noguchi M; Kumaki T; Taniya T; Segawa M; Nakano T; Ohta N; Miyazaki I
    Int Surg; 1990; 75(4):220-4. PubMed ID: 2292479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Predictors of level V lymphatic metastasis in papillary thyroid carcinoma].
    Chen R; Wei T; Li ZH; Gong RX; Zhu JQ
    Zhonghua Wai Ke Za Zhi; 2012 Jul; 50(7):625-8. PubMed ID: 22943994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Poorly differentiated thyroid follicular carcinoma - a clinical analysis of 30 cases].
    Liu WS; Qi YF; Tang PZ
    Ai Zheng; 2004 Sep; 23(9):1081-4. PubMed ID: 15363207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical management and outcomes in patients with hyperfunctioning distant metastases from differentiated thyroid cancer after total thyroidectomy and radioactive iodine therapy.
    Qiu ZL; Shen CT; Luo QY
    Thyroid; 2015 Feb; 25(2):229-37. PubMed ID: 25331724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term results in elderly patients with differentiated thyroid carcinoma.
    Vini L; Hyer SL; Marshall J; A'Hern R; Harmer C
    Cancer; 2003 Jun; 97(11):2736-42. PubMed ID: 12767085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive factors and pattern of central lymph node metastasis in unilateral papillary thyroid carcinoma.
    Ji YB; Yoo HS; Song CM; Park CW; Lee CB; Tae K
    Auris Nasus Larynx; 2016 Feb; 43(1):79-83. PubMed ID: 26441368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
    Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
    Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.